EE200200260A - Pürasolo[1,5-d][1,2,4]triasiinderivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud kognitsiooni suurendamiseks, ning seda sisaldav farmatseutiline kompositsioon - Google Patents
Pürasolo[1,5-d][1,2,4]triasiinderivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud kognitsiooni suurendamiseks, ning seda sisaldav farmatseutiline kompositsioonInfo
- Publication number
- EE200200260A EE200200260A EEP200200260A EEP200200260A EE200200260A EE 200200260 A EE200200260 A EE 200200260A EE P200200260 A EEP200200260 A EE P200200260A EE P200200260 A EEP200200260 A EE P200200260A EE 200200260 A EE200200260 A EE 200200260A
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- pyrazolo
- cognition
- medicament
- enhancement
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9927874.9A GB9927874D0 (en) | 1999-11-25 | 1999-11-25 | Therapeutic agents |
GB0009602A GB0009602D0 (en) | 2000-04-18 | 2000-04-18 | Therapeutic agents |
GB0018651A GB0018651D0 (en) | 2000-07-28 | 2000-07-28 | Therapeutic agents |
PCT/GB2000/004450 WO2001038331A2 (fr) | 1999-11-25 | 2000-11-22 | Groupe pyrazolo[1,5-d][1,2,4]triazines destine a ameliorer la cognition |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200200260A true EE200200260A (et) | 2003-06-16 |
Family
ID=27255677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200200260A EE200200260A (et) | 1999-11-25 | 2000-11-22 | Pürasolo[1,5-d][1,2,4]triasiinderivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud kognitsiooni suurendamiseks, ning seda sisaldav farmatseutiline kompositsioon |
Country Status (20)
Country | Link |
---|---|
US (1) | US6355638B1 (fr) |
EP (1) | EP1235829A2 (fr) |
JP (1) | JP2003514909A (fr) |
KR (1) | KR20020053091A (fr) |
CN (1) | CN1391574A (fr) |
AU (1) | AU1533001A (fr) |
BG (1) | BG106734A (fr) |
BR (1) | BR0015126A (fr) |
CA (1) | CA2391103A1 (fr) |
CZ (1) | CZ20021813A3 (fr) |
EA (1) | EA200200599A1 (fr) |
EE (1) | EE200200260A (fr) |
HK (1) | HK1046406A1 (fr) |
HU (1) | HUP0203579A3 (fr) |
IL (1) | IL149051A0 (fr) |
MX (1) | MXPA02005233A (fr) |
NO (1) | NO20022456L (fr) |
PL (1) | PL355637A1 (fr) |
SK (1) | SK8952002A3 (fr) |
WO (1) | WO2001038331A2 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0128499D0 (en) * | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
EP2298296A1 (fr) * | 2009-08-25 | 2011-03-23 | CNRS Centre National De La Recherche Scientifique | Composition et procédé pour le traitement de troubles cognitifs chez des sujets atteints du syndrome de Down |
CN103038229B (zh) * | 2010-05-26 | 2016-05-11 | 桑诺维恩药品公司 | 杂芳基化合物及其使用方法 |
US20150374705A1 (en) | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
CN107344938B (zh) * | 2016-05-06 | 2022-05-06 | 上海赛默罗生物科技有限公司 | 吡唑-三嗪类衍生物、其制备方法、药物组合物和用途 |
CN107344936B (zh) * | 2016-05-06 | 2022-06-03 | 上海赛默罗生物科技有限公司 | 三唑哒嗪类衍生物、其制备方法、药物组合物和用途 |
KR20220048489A (ko) * | 2019-06-19 | 2022-04-19 | 바이오마린 파머수티컬 인크. | 질환의 치료를 위한 글리콜레이트 산화효소 억제제 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998004559A2 (fr) * | 1996-07-25 | 1998-02-05 | Merck Sharp & Dohme Limited | Derives de triazolo-pyridazine substitues servant de ligands pour recepteurs de gaba |
GB9715977D0 (en) * | 1997-07-29 | 1997-10-01 | Merck Sharp & Dohme | Therapeutic agents |
JP2002509150A (ja) * | 1998-01-14 | 2002-03-26 | メルク シャープ エンド ドーム リミテッド | Gaba受容体のリガンドとしてのトリアゾロピリダジン誘導体 |
GB9806102D0 (en) * | 1998-03-20 | 1998-05-20 | Merck Sharp & Dohme | Therapeutic agents |
EP1087968A1 (fr) * | 1998-06-16 | 2001-04-04 | MERCK SHARP & DOHME LTD. | Derives de triazolo-pyridine comme ligands de recepteurs de gaba |
JP2002527519A (ja) * | 1998-10-16 | 2002-08-27 | メルク シャープ エンド ドーム リミテッド | Gaba受容体のリガンドとしてのピラゾロトリアジン誘導体 |
-
2000
- 2000-11-21 US US09/717,423 patent/US6355638B1/en not_active Expired - Lifetime
- 2000-11-22 KR KR1020027006672A patent/KR20020053091A/ko not_active Application Discontinuation
- 2000-11-22 EP EP00977692A patent/EP1235829A2/fr not_active Withdrawn
- 2000-11-22 SK SK895-2002A patent/SK8952002A3/sk unknown
- 2000-11-22 CA CA002391103A patent/CA2391103A1/fr not_active Abandoned
- 2000-11-22 BR BR0015126-2A patent/BR0015126A/pt not_active Application Discontinuation
- 2000-11-22 EE EEP200200260A patent/EE200200260A/xx unknown
- 2000-11-22 CZ CZ20021813A patent/CZ20021813A3/cs unknown
- 2000-11-22 AU AU15330/01A patent/AU1533001A/en not_active Abandoned
- 2000-11-22 MX MXPA02005233A patent/MXPA02005233A/es not_active Application Discontinuation
- 2000-11-22 IL IL14905100A patent/IL149051A0/xx unknown
- 2000-11-22 JP JP2001540094A patent/JP2003514909A/ja not_active Withdrawn
- 2000-11-22 CN CN00816013A patent/CN1391574A/zh active Pending
- 2000-11-22 HU HU0203579A patent/HUP0203579A3/hu unknown
- 2000-11-22 WO PCT/GB2000/004450 patent/WO2001038331A2/fr not_active Application Discontinuation
- 2000-11-22 EA EA200200599A patent/EA200200599A1/ru unknown
- 2000-11-22 PL PL00355637A patent/PL355637A1/xx not_active Application Discontinuation
-
2002
- 2002-05-22 BG BG106734A patent/BG106734A/xx unknown
- 2002-05-24 NO NO20022456A patent/NO20022456L/no not_active Application Discontinuation
- 2002-10-29 HK HK02107821.8A patent/HK1046406A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EA200200599A1 (ru) | 2002-12-26 |
PL355637A1 (en) | 2004-05-04 |
NO20022456D0 (no) | 2002-05-24 |
CN1391574A (zh) | 2003-01-15 |
MXPA02005233A (es) | 2002-11-07 |
EP1235829A2 (fr) | 2002-09-04 |
KR20020053091A (ko) | 2002-07-04 |
AU1533001A (en) | 2001-06-04 |
WO2001038331A3 (fr) | 2001-11-08 |
IL149051A0 (en) | 2002-11-10 |
CA2391103A1 (fr) | 2001-05-31 |
SK8952002A3 (en) | 2002-10-08 |
HK1046406A1 (zh) | 2003-01-10 |
HUP0203579A3 (en) | 2003-07-28 |
BR0015126A (pt) | 2002-07-02 |
WO2001038331A2 (fr) | 2001-05-31 |
HUP0203579A2 (hu) | 2003-03-28 |
NO20022456L (no) | 2002-05-24 |
JP2003514909A (ja) | 2003-04-22 |
BG106734A (en) | 2003-02-28 |
US6355638B1 (en) | 2002-03-12 |
CZ20021813A3 (cs) | 2002-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200200046A (et) | 8-fenüül-6,9-dihüdro-[1,2,4]triasolo[3,4-i]puriin-5-ooni derivaat, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon | |
EE04850B1 (et) | Pürimidiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ning kombineeritud preparaat kasutamiseks HIV nakku | |
EE05404B1 (et) | Kinuklidiini derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nhtud respiratoorsete, kuseelundite v?i mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon | |
EE200300295A (et) | Kinuklidiinkarbamaadi derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud respiratoorsete, kuseelundite või mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon | |
HUP0203131A3 (en) | Amino substituted pyrazolo[1,5-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines, pharmaceutical compositions containing them and their use | |
EE200100318A (et) | Kinoliini derivaat, selle ühendi kasutamine ravimina, seda sisaldav farmatseutiline kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks | |
HUP0104867A3 (en) | Heterocyclic compounds useful in the treatment of inflammatory diseases, process for their preparation, pharmaceutical compositions comprising thereof and their use | |
EE200000535A (et) | Triasendatud 1,3,5-triasiini derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud HIV nakkuse raviks, ühend, seda sisaldav farmatseutiline kompositsioon, meetod ühendi ja kompositsiooni valmistamiseks ning kombineeritud preparaat kasutami | |
IL128869A (en) | ARYSULFONYL-SUBSTITUTED-PYRAZOLO [1,5-a]-PYRIMIDINE AND PYRAZOLO [1,5-a] [1, 3, 5]-TRIAZINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
HUP0105081A3 (en) | Triazolo[4,5-d]pyrimidine derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0203142A3 (en) | Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
EE03613B1 (et) | Omeprasooli naatriumisool,selle valmistamise protsess,seda sisaldav ravimkoostis ja selle kasutamine seedetrakti häirete ravimiseks | |
HUP0202678A3 (en) | Certain alkylene diamine-substituted pyrazolo[1,5,-a]-1,5-pyrimidines and pyrazolo[1,5-a]-1,3,5-triazines, pharmaceutical compositions containing them and their use | |
EE200000483A (et) | Glütsiini ülekannet pärssiva ühendi kasutamine ravimi valmistamiseks, ühend, seda sisaldav kompositsioon ning meetod ühendi ja kompositsiooni valmistamiseks | |
HUP0204431A3 (en) | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use, process for their preparation and pharmaceutical compositions containing them | |
EE200000596A (et) | Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja kasutamine ning vaheühend ja selle valmistamismeetod | |
HUP0002902A3 (en) | 3-substituted 3,4 dyhydro-thieno[2,3-d]pyrimidine derivatives and their use for the preparation of pharmaceutical compositions | |
EE05082B1 (et) | Pürroolirea ühend, selle valmistamine ja kasutamine lipiidi- ja kolesteroolitaset alandava ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon | |
EE05127B1 (et) | Osadest koosnev komplekt ja ravimpreparaat, mis sisaldavad P2T-retseptori antagonisti v?i selle farmatseutiliselt vastuv?etavat derivaati ja tromboosivastast ainet, ning nende kasutamine meditsiinis | |
EE200100388A (et) | Püridasino [4,5-b] indool-1-atseetamiidi derivaatide kasutamine ravimite valmistamiseks perifeersete bensodiasepiiniretseptorite düsfunktsioneerimisega seotud haiguste raviks | |
EE04493B1 (et) | Tsüklopenteeni derivaadid, neid sisaldav farmatseutiline kompositsioon ning ühendite kasutamine ravimina inimestel esinevate motiliini retseptoriga seotud häirete raviks | |
HUP0105132A3 (en) | Process for preparing imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones and the use of the same for preparing pharmaceutical compositions | |
EE200000767A (et) | Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon | |
EE200200057A (et) | Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon | |
EE200200260A (et) | Pürasolo[1,5-d][1,2,4]triasiinderivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud kognitsiooni suurendamiseks, ning seda sisaldav farmatseutiline kompositsioon |